{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:08:46Z","timestamp":1793419726283,"version":"4.5.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.bcp.2024.116100","type":"journal-article","created":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T01:02:12Z","timestamp":1709168532000},"page":"116100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Expression and function of VISTA on myeloid cells"],"prefix":"10.1016","volume":"222","author":[{"given":"Siyu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjun","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanru","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canxia","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suling","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1056-3264","authenticated-orcid":false,"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2024.116100_b0005","doi-asserted-by":"crossref","DOI":"10.1126\/science.1261669","article-title":"Control of signaling-mediated clearance of apoptotic cells by the tumor suppressor p53","volume":"349","author":"Yoon","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.bcp.2024.116100_b0010","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.4049\/jimmunol.1100660","article-title":"Cutting edge: a monoclonal antibody specific for the programmed death-1 homolog prevents graft-versus-host disease in mouse models","volume":"187","author":"Flies","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.bcp.2024.116100_b0015","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1172\/JCI74589","article-title":"Coinhibitory receptor PD-1H preferentially suppresses CD4(+) T cell-mediated immunity","volume":"124","author":"Flies","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bcp.2024.116100_b0020","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.645388","article-title":"Mining TCGA data for key biomarkers related to immune microenvironment in endometrial cancer by immune score and weighted correlation network analysis","volume":"8","author":"Guo","year":"2021","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.bcp.2024.116100_b0025","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/s41590-019-0512-0","article-title":"Inhibitory receptors and ligands beyond PD-1, PD-L1 and CTLA-4: breakthroughs or backups","volume":"20","author":"Andrews","year":"2019","journal-title":"Nat Immunol"},{"key":"10.1016\/j.bcp.2024.116100_b0030","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1111\/j.1349-7006.2010.01675.x","article-title":"GI24 enhances tumor invasiveness by regulating cell surface membrane-type 1 matrix metalloproteinase","volume":"101","author":"Sakr","year":"2010","journal-title":"Cancer Sci"},{"key":"10.1016\/j.bcp.2024.116100_b0035","article-title":"Morin, the PPARgamma agonist, inhibits Th17 differentiation by limiting fatty acid synthesis in collagen-induced arthritis","author":"Miao","year":"2022","journal-title":"Cell Biol Toxicol"},{"key":"10.1016\/j.bcp.2024.116100_b0040","doi-asserted-by":"crossref","first-page":"7776","DOI":"10.1074\/jbc.M109.077156","article-title":"Differentiation of embryonic stem cells 1 (Dies1) is a component of bone morphogenetic protein 4 (BMP4) signaling pathway required for proper differentiation of mouse embryonic stem cells","volume":"285","author":"Aloia","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2024.116100_b0045","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s13075-017-1474-y","article-title":"VISTA deficiency attenuates antibody-induced arthritis and alters macrophage gene expression in response to simulated immune complexes","volume":"19","author":"Ceeraz","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.bcp.2024.116100_b0050","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1084\/jem.20100619","article-title":"VISTA, a novel mouse ig superfamily ligand that negatively regulates T cell responses","volume":"208","author":"Wang","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.bcp.2024.116100_b0055","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.it.2013.07.003","article-title":"B7 family checkpoint regulators in immune regulation and disease","volume":"34","author":"Ceeraz","year":"2013","journal-title":"Trends Immunol"},{"key":"10.1016\/j.bcp.2024.116100_b0060","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.semcancer.2017.10.001","article-title":"Emerging targets in cancer immunotherapy","volume":"52","author":"Burugu","year":"2018","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.bcp.2024.116100_b0065","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s00109-020-01968-x","article-title":"Exploring the VISTA of microglia: immune checkpoints in CNS inflammation","volume":"98","author":"Borggrewe","year":"2020","journal-title":"J Mol Med (berl)"},{"key":"10.1016\/j.bcp.2024.116100_b0070","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.940930","article-title":"The neonatal innate immune response to sepsis: checkpoint proteins as novel mediators of this response and as possible therapeutic\/diagnostic levers","volume":"13","author":"Hensler","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.bcp.2024.116100_b0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109103","article-title":"Characterization of programmed death-1 homologue-1 (PD-1H) expression and function in normal and HIV infected individuals","volume":"9","author":"Bharaj","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2024.116100_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2019.101308","article-title":"VISTA: a novel immunotherapy target for normalizing innate and adaptive immunity","volume":"42","author":"ElTanbouly","year":"2019","journal-title":"Semin Immunol"},{"key":"10.1016\/j.bcp.2024.116100_b0085","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1158\/2326-6066.CIR-18-0489","article-title":"Immune-checkpoint protein VISTA regulates antitumor immunity by controlling myeloid cell-mediated inflammation and immunosuppression","volume":"7","author":"Xu","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.bcp.2024.116100_b0090","article-title":"VISTA: a target to manage the innate cytokine storm","volume":"11","author":"ElTanbouly","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.bcp.2024.116100_b0095","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13045-020-00917-y","article-title":"VISTA: an immune regulatory protein checking tumor and immune cells in cancer immunotherapy","volume":"13","author":"Huang","year":"2020","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.bcp.2024.116100_b0100","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1830524","article-title":"Converging focal radiation and immunotherapy in a preclinical model of triple negative breast cancer: contribution of VISTA blockade","volume":"9","author":"Pilones","year":"2020","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.bcp.2024.116100_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115492","article-title":"Chemotherapy induces immune checkpoint VISTA expression in tumor cells via HIF-2alpha","volume":"210","author":"Li","year":"2023","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2024.116100_b0110","doi-asserted-by":"crossref","DOI":"10.1007\/s12072-023-10505-0","article-title":"Downregulated VISTA enhances Th17 differentiation and aggravates inflammation in patients with acute-on-chronic liver failure","author":"Zhang","year":"2023","journal-title":"Hepatol Int"},{"key":"10.1016\/j.bcp.2024.116100_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2020.02.002","article-title":"The expression and immunoregulation of immune checkpoint molecule VISTA in autoimmune diseases and cancers","volume":"52","author":"Wang","year":"2020","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.bcp.2024.116100_b0120","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003382","article-title":"Rationally targeted anti-VISTA antibody that blockades the C-C' loop region can reverse VISTA immune suppression and remodel the immune microenvironment to potently inhibit tumor growth in an Fc independent manner","volume":"10","author":"Thakkar","year":"2022","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.bcp.2024.116100_b0125","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1007\/s00262-022-03205-5","article-title":"Opening up new VISTAs: V-domain immunoglobulin suppressor of T cell activation (VISTA) targeted near-infrared photoimmunotherapy (NIR-PIT) for enhancing host immunity against cancers","volume":"71","author":"Wakiyama","year":"2022","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.bcp.2024.116100_b0130","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12967-017-1141-8","article-title":"Immune modulation of some autoimmune diseases: the critical role of macrophages and neutrophils in the innate and adaptive immunity","volume":"15","author":"Navegantes","year":"2017","journal-title":"J Transl Med"},{"key":"10.1016\/j.bcp.2024.116100_b0135","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1182\/blood-2018-11-844548","article-title":"Neutrophil plasticity in the tumor microenvironment","volume":"133","author":"Giese","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2024.116100_b0140","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax1159","article-title":"PD-1H (VISTA)-mediated suppression of autoimmunity in systemic and cutaneous lupus erythematosus","volume":"11","author":"Han","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.bcp.2024.116100_b0145","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1038\/s41598-017-01411-1","article-title":"Immune-checkpoint protein VISTA critically regulates the IL-23\/IL-17 inflammatory axis","volume":"7","author":"Li","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.bcp.2024.116100_b0150","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1136\/annrheumdis-2018-214627","article-title":"Running promotes chronicity of arthritis by local modulation of complement activators and impairing T regulatory feedback loops","volume":"78","author":"Cambre","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.bcp.2024.116100_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102501","article-title":"VISTA deficiency protects from immune complex-mediated glomerulonephritis by inhibiting neutrophil activation","volume":"113","author":"Tham","year":"2020","journal-title":"J Autoimmun"},{"key":"10.1016\/j.bcp.2024.116100_b0160","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/MPA.0000000000001059","article-title":"High-density infiltration of V-domain immunoglobulin suppressor of T-cell activation up-regulated immune cells in human pancreatic cancer","volume":"47","author":"Liu","year":"2018","journal-title":"Pancreas"},{"key":"10.1016\/j.bcp.2024.116100_b0165","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s00262-018-2169-1","article-title":"VISTA expression on tumor-infiltrating inflammatory cells in primary cutaneous melanoma correlates with poor disease-specific survival","volume":"67","author":"Kuklinski","year":"2018","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.bcp.2024.116100_b0170","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41392-022-01136-2","article-title":"Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.bcp.2024.116100_b0175","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/s41598-020-57627-1","article-title":"The adaptive and innate immune cell landscape of uterine leiomyosarcomas","volume":"10","author":"Manzoni","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.bcp.2024.116100_b0180","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1158\/0008-5472.CAN-13-1504","article-title":"VISTA is an immune checkpoint molecule for human T cells","volume":"74","author":"Lines","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2024.116100_b0185","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.837097","article-title":"Macrophage differentiation and polarization regulate the release of the immune checkpoint protein V-domain ig suppressor of T cell activation","volume":"13","author":"Noubissi Nzeteu","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.bcp.2024.116100_b0190","article-title":"Characterization of immune cell subsets of tumor infiltrating lymphocytes in brain metastases","volume":"10","author":"Croft","year":"2021","journal-title":"Biology (basel)"},{"key":"10.1016\/j.bcp.2024.116100_b0195","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/glia.23517","article-title":"VISTA expression by microglia decreases during inflammation and is differentially regulated in CNS diseases","volume":"66","author":"Borggrewe","year":"2018","journal-title":"Glia"},{"key":"10.1016\/j.bcp.2024.116100_b0200","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1126\/science.aba5906","article-title":"Human fetal microglia acquire homeostatic immune-sensing properties early in development","volume":"369","author":"Kracht","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.bcp.2024.116100_b0205","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.kint.2019.11.025","article-title":"Kidney residency of VISTA-positive macrophages accelerates repair from ischemic injury","volume":"97","author":"Park","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.bcp.2024.116100_b0210","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3389\/fimmu.2014.00461","article-title":"Toll-like receptor signaling pathways","volume":"5","author":"Kawasaki","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.bcp.2024.116100_b0215","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev.immunol.21.120601.141126","article-title":"Toll-like receptors","volume":"21","author":"Takeda","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.bcp.2024.116100_b0220","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1073\/pnas.0308496101","article-title":"Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at toll-IL-1 receptor domain-containing adapter inducing IFN-beta","volume":"101","author":"Jiang","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bcp.2024.116100_b0225","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1038\/sj.onc.1210413","article-title":"Ubiquitin-mediated activation of TAK1 and IKK","volume":"26","author":"Adhikari","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2024.116100_b0230","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/art.40020","article-title":"VISTA deficiency accelerates the development of fatal murine lupus nephritis","volume":"69","author":"Ceeraz","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.bcp.2024.116100_b0235","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.580187","article-title":"VISTA re-programs macrophage biology through the combined regulation of tolerance and anti-inflammatory pathways","volume":"11","author":"ElTanbouly","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.bcp.2024.116100_b0240","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.3389\/fimmu.2019.02641","article-title":"Defining the signature of VISTA on myeloid cell chemokine responsiveness","volume":"10","author":"Broughton","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.bcp.2024.116100_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2022.104581","article-title":"VISTA as a ligand downregulates LPS-mediated inflammation in macrophages and neutrophils","volume":"379","author":"Vivian Ma","year":"2022","journal-title":"Cell Immunol"},{"key":"10.1016\/j.bcp.2024.116100_b0250","doi-asserted-by":"crossref","first-page":"10483","DOI":"10.7150\/thno.45614","article-title":"Single-cell RNA-seq reveals the transcriptional landscape and heterogeneity of skin macrophages in vsir(-\/-) murine psoriasis","volume":"10","author":"Qie","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.bcp.2024.116100_b0255","doi-asserted-by":"crossref","first-page":"35466","DOI":"10.1038\/srep35466","article-title":"aureus blocks efferocytosis of neutrophils by macrophages through the activity of its virulence factor alpha toxin","volume":"6","author":"Cohen","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.bcp.2024.116100_b0260","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ccell.2021.11.002","article-title":"The allergy mediator histamine confers resistance to immunotherapy in cancer patients via activation of the macrophage histamine receptor H1","volume":"40","author":"Li","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcp.2024.116100_b0265","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nm.4308","article-title":"VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer","volume":"23","author":"Gao","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.bcp.2024.116100_b0270","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc8511","article-title":"Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications","volume":"369","author":"Mathew","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.bcp.2024.116100_b0275","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/s41591-020-0944-y","article-title":"A single-cell atlas of the peripheral immune response in patients with severe COVID-19","volume":"26","author":"Wilk","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.bcp.2024.116100_b0280","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1165\/rcmb.2022-0219OC","article-title":"VISTA (PD-1H) is a crucial immune regulator to limit pulmonary fibrosis","volume":"69","author":"Kim","year":"2023","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.bcp.2024.116100_b0285","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6650329","article-title":"High-affinity anti-VISTA antibody protects against sepsis by inhibition of T lymphocyte apoptosis and suppression of the inflammatory response","volume":"2021","author":"Tao","year":"2021","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.bcp.2024.116100_b0290","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.4049\/jimmunol.1102310","article-title":"Role of C3a receptors, C5a receptors, and complement protein C6 deficiency in collagen antibody-induced arthritis in mice","volume":"188","author":"Banda","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.bcp.2024.116100_b0295","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1469594","article-title":"VISTA is highly expressed on MDSCs and mediates an inhibition of T cell response in patients with AML","volume":"7","author":"Wang","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.bcp.2024.116100_b0300","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.811867","article-title":"TNF-alpha-secreting lung tumor-infiltrated monocytes play a pivotal role during anti-PD-L1 immunotherapy","volume":"13","author":"De Ridder","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.bcp.2024.116100_b0305","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.563044","article-title":"The expression pattern and clinical significance of the immune checkpoint regulator VISTA in human breast cancer","volume":"11","author":"Xie","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.bcp.2024.116100_b0310","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s11102-020-01114-3","article-title":"Immune profiling of pituitary tumors reveals variations in immune infiltration and checkpoint molecule expression","volume":"24","author":"Mei","year":"2021","journal-title":"Pituitary"},{"key":"10.1016\/j.bcp.2024.116100_b0315","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.it.2020.12.008","article-title":"VISTA: a mediator of quiescence and a promising target in cancer immunotherapy","volume":"42","author":"Yuan","year":"2021","journal-title":"Trends Immunol"},{"key":"10.1016\/j.bcp.2024.116100_b0320","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1158\/2326-6066.CIR-18-0507","article-title":"Hypoxia-induced VISTA promotes the suppressive function of myeloid-derived suppressor cells in the tumor microenvironment","volume":"7","author":"Deng","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.bcp.2024.116100_b0325","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1073\/pnas.1811067116","article-title":"Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer","volume":"116","author":"Blando","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bcp.2024.116100_b0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.09.064","article-title":"CNS-native myeloid cells drive immune suppression in the brain metastatic niche through Cxcl10","volume":"183","author":"Guldner","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2024.116100_b0335","article-title":"Effective antitumor immunity can be triggered by targeting VISTA in combination with a TLR3-specific adjuvant. cancer","author":"Wang","year":"2023","journal-title":"Immunol Res"},{"key":"10.1016\/j.bcp.2024.116100_b0340","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41577-020-00490-y","article-title":"Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity","volume":"21","author":"Veglia","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bcp.2024.116100_b0345","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.658488","article-title":"Terminating cancer by blocking VISTA as a novel immunotherapy: hasta la vista, baby","volume":"11","author":"Yum","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.bcp.2024.116100_b0350","doi-asserted-by":"crossref","first-page":"9693","DOI":"10.1128\/JVI.00888-15","article-title":"Selective involvement of the checkpoint regulator VISTA in suppression of B-cell, but not T-cell, responsiveness by monocytic myeloid-derived suppressor cells from mice infected with an immunodeficiency-causing retrovirus","volume":"89","author":"Green","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.bcp.2024.116100_b0355","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/832454","article-title":"Regulation of antitumor immune responses by the IL-12 family cytokines, IL-12, IL-23, and IL-27","volume":"2010","author":"Xu","year":"2010","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.bcp.2024.116100_b0360","doi-asserted-by":"crossref","first-page":"14372","DOI":"10.1038\/s41598-020-71216-2","article-title":"The prognostic significance of VISTA and CD33-positive myeloid cells in cutaneous melanoma and their relationship with PD-1 expression","volume":"10","author":"Choi","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.bcp.2024.116100_b0365","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1158\/0008-5472.CAN-13-1506","article-title":"VISTA regulates the development of protective antitumor immunity","volume":"74","author":"Le Mercier","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2024.116100_b0370","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/s42003-021-02381-x","article-title":"Inhibition of lung tumorigenesis by a small molecule CA170 targeting the immune checkpoint protein VISTA","volume":"4","author":"Pan","year":"2021","journal-title":"Commun Biol"},{"key":"10.1016\/j.bcp.2024.116100_b0375","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","article-title":"Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion","volume":"21","author":"Jhunjhunwala","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bcp.2024.116100_b0380","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1038\/s41423-021-00726-4","article-title":"Dendritic cell migration in inflammation and immunity","volume":"18","author":"Liu","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.bcp.2024.116100_b0385","doi-asserted-by":"crossref","first-page":"14846","DOI":"10.1073\/pnas.1407447111","article-title":"Disruption of the immune-checkpoint VISTA gene imparts a proinflammatory phenotype with predisposition to the development of autoimmunity","volume":"111","author":"Wang","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bcp.2024.116100_b0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e07496","article-title":"VISTA facilitates phagocytic clearance of HIV infected CEM-SS T cells","volume":"7","author":"Xu","year":"2021","journal-title":"Heliyon"},{"key":"10.1016\/j.bcp.2024.116100_b0400","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24152804","article-title":"CA-170 - a potent small-molecule PD-L1 inhibitor or not?","volume":"24","author":"Musielak","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.bcp.2024.116100_b0405","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.862757","article-title":"Distinct immune stimulatory effects of anti-human VISTA antibodies are determined by fc-receptor interaction","volume":"13","author":"Mostbock","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.bcp.2024.116100_b0410","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.semcancer.2021.08.008","article-title":"Immune functions as a ligand or a receptor, cancer prognosis potential, clinical implication of VISTA in cancer immunotherapy","volume":"86","author":"Im","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.bcp.2024.116100_b0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112470","article-title":"Biomarkers related to immune checkpoint inhibitors therapy","volume":"147","author":"Li","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.bcp.2024.116100_b0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108803","article-title":"Adverse and unconventional reactions related to immune checkpoint inhibitor therapy for cancer","volume":"108","author":"Li","year":"2022","journal-title":"Int Immunopharmacol"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224000832?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224000832?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T08:51:38Z","timestamp":1717836698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295224000832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":83,"alternative-id":["S0006295224000832"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116100","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression and function of VISTA on myeloid cells","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116100","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116100"}}